Results
205
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
205 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$58.34 | -6.1% | 109.3% | US$18.7b | US$62.47 | PE134.1x | E29.7% | n/a | Consumer Durables | ||
KINS | US$17.88 | 14.6% | 451.8% | US$207.2m | US$18.00 | PE13.9x | E24.9% | 0% | Insurance | ||
ATAT | US$27.60 | 0.4% | 51.6% | US$3.7b | US$33.20 | PE23.6x | E25.2% | 1.6% | Consumer Services | ||
TBBB | US$29.39 | -2.7% | n/a | US$3.5b | US$34.04 | PE258.9x | E40.4% | n/a | Consumer Retailing | ||
SMCI | US$29.16 | 3.5% | -57.2% | US$15.7b | US$40.79 | PE14.1x | E24.3% | n/a | Tech | ||
CACC | US$518.72 | -1.3% | -6.5% | US$6.2b | US$483.75 | PE25.2x | E33.8% | n/a | Diversified Financials | ||
CLNN | US$4.65 | -1.5% | -48.3% | US$36.5m | US$45.17 | PS88.1x | E59.1% | n/a | Pharmaceuticals & Biotech | ||
OSTX | US$1.93 | -25.8% | n/a | US$37.2m | US$14.67 | PE-5.5x | E23.8% | n/a | Pharmaceuticals & Biotech | ||
DUOT | US$6.42 | 7.7% | 46.9% | US$54.7m | US$8.75 | PS7.3x | E90.4% | n/a | Software | ||
ULBI | US$7.35 | -6.7% | 6.1% | US$121.7m | US$14.00 | PE13.6x | E43.8% | n/a | Capital Goods | ||
ZAPP New | US$0.93 | -12.3% | -83.5% | US$4.9m | US$19.33 | PS262.7x | E106.8% | n/a | Automobiles | ||
SMWB | US$17.32 | 4.0% | 195.6% | US$1.4b | US$16.50 | PS5.9x | E92.4% | n/a | Software | ||
SPRY | US$12.52 | -15.9% | 92.6% | US$1.2b | US$27.25 | PS473.8x | E58.7% | n/a | Pharmaceuticals & Biotech | ||
TRUG | US$0.43 | -8.7% | -72.4% | US$8.9m | US$2.50 | PS0.4x | E58.0% | n/a | Media | ||
NEON | US$8.77 | 5.0% | 444.7% | US$147.5m | US$10.25 | PS38.8x | E110.9% | n/a | Tech | ||
CBNK | US$31.48 | 2.1% | 51.8% | US$510.8m | US$35.25 | PB1.5x | E28.6% | 1.3% | Banks | ||
RYAN | US$68.45 | 4.6% | 59.6% | US$17.7b | US$73.98 | PE84.2x | E43.9% | 0.6% | Insurance | ||
HSAI | US$15.69 | 4.3% | 265.7% | US$2.0b | US$13.09 | PS7.6x | E68.2% | n/a | Automobiles | ||
ZS | US$203.73 | -0.5% | -13.2% | US$30.7b | US$226.04 | PS13.6x | E39.7% | n/a | Software | ||
XPEV | US$16.99 | 12.4% | 93.3% | US$14.9b | US$14.80 | PS3.1x | E56.7% | n/a | Automobiles | ||
SPOT | US$621.77 | 17.1% | 168.1% | US$111.0b | US$538.76 | PE106.3x | E23.8% | n/a | Media | ||
CKPT New | US$3.39 | 17.3% | 69.5% | US$154.8m | US$12.00 | PS3522.2x | E46.1% | n/a | Pharmaceuticals & Biotech | ||
MP | US$24.47 | 17.5% | 46.5% | US$3.6b | US$23.55 | PS21.7x | E76.7% | n/a | Materials | ||
EH | US$16.95 | -0.3% | 58.0% | US$1.1b | US$24.18 | PS22.3x | E81.2% | n/a | Capital Goods |